Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome-Reference-Cited by-同舟云学术

Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome

Published:2001-03 Issue:5 Volume:87 Page:663-666
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Roman Mary J.,Salmon Jane E.,Sobel Rachel,Lockshin Michael D.,Sammaritano Lisa,Schwartz Joseph E.,Devereux Richard B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Risk factors for coronary artery disease in patients with SLE;Petri;Am J Med,1992

2. Coronary artery disease risk factors in the Johns Hopkins SLE cohort;Petri;Medicine,1992

3. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus—comparison with the Framingham study;Manzi;Am J Epidemiol,1997

4. Manzi S, Selzer F, Sutton-Tyrrell, Fitzgerald SG, Rairie JE, Tracy RP, Kuller LH. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:51–60.

5. Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease;Glueck;Am J Cardiol,1999

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carga de enfermedad cardiovascular en enfermedad reumatológica autoinmune: “el corazón en lupus y la artritis reumatoide”;Universitas Médica;2023-07-04

2. Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases;Metabolites;2023-06-01

3. Antibodies against phosphorylcholine and protection against atherosclerosis, cardiovascular disease and chronic inflammation;Expert Review of Clinical Immunology;2022-05-01

4. Multimodality Cardiac Imaging in Patients with Systemic Lupus Erythematosus;Current Problems in Cardiology;2021-11

5. Cardiovascular complications of systemic lupus erythematosus: impact of risk factors and therapeutic efficacy—a tertiary centre experience in an Appalachian state;Lupus Science & Medicine;2021-05